Publication | Closed Access

Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study

Hematological MalignancyJalsg Aml201 StudyGenetic DisorderImmunologyHematologyPathologyAml PatientsCell BiologyAdult T-cell Leukemia-lymphomaMedicineZbtb7a MutationsMyeloid Neoplasia